Acquisition of Parlux (Tables)

12 Months Ended

Feb. 01, 2014

Schedule of Purchase Price, Assets Acquired, and Liabilities Assumed

The following tables summarize the purchase price and the assets acquired and liabilities assumed as of the acquisition date at estimated fair value:



(in thousands except price per share)
Proceeds from Senior Credit Facility		$	32,062
Proceeds from notes payable to affiliates		30,000
Total cash consideration		62,062

Total shares of Perfumania common stock issued (1)	6,314
Perfumania price per share, April 18, 2012	$9.38	59,225

Fair value of Perfumania stock options and warrants issued		30,338

Total purchase price		$	151,625

(1) Includes 300 shares issued pursuant to various licensing agreements

Schedule of Purchase Price Allocation



(in thousands)
Cash	$	17,114
Accounts receivable	21,242
Inventories	60,966
Other current assets	10,841
Property and equipment	1,107
Other non-current assets	167
Identified intangible assets	24,676
Goodwill	38,769
Accounts payable	(16,032		)
Deferred tax liabilities	(3,239		)
Other liabilities assumed	(3,986		)
Net assets acquired	$	151,625

Schedule of Estimated Future Amortization Expense

The estimated future amortization expense associated with intangible assets subject to amortization is as follows (in thousands):



Fiscal Year	Amortization Expense
2014	$	4,415
2015	4,415
2016	1,845
2017	1,330
2018	999
Thereafter	2,314
	$	15,318

Schedule of Pro Forma Financial Information

Accordingly, the unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the acquisition been consummated as of January 28, 2012.



	Fiscal Year Ended February 2, 2013
	(in thousands, except per share data)
Net sales	$	554,648
Net loss	(53,501		)
Net loss per share - basic	$	(2.64	)
Net loss per share - diluted	(2.64		)